Literature DB >> 1656855

Imipenem- and meropenem-resistant mutants of Enterobacter cloacae and Proteus rettgeri lack porins.

A Raimondi1, A Traverso, H Nikaido.   

Abstract

Carbapenems such as imipenem and meropenem are not rapidly hydrolyzed by commonly occurring beta-lactamases. Nevertheless, it was possible, by mutagenesis and selection, to isolate mutant strains of Enterobacter cloacae and Proteus rettgeri that are highly resistant to meropenem and imipenem. Two alterations were noted in the E. cloacae mutants. First, the mutant strains appeared to be strongly derepressed in the production of beta-lactamases, which reached a very high level when the strains were grown in the presence of imipenem. Second, these mutants were deficient in the production of nonspecific porins, as judged by the pattern of outer membrane proteins as well as by reconstitution assays of permeability. As with most porin-deficient mutants, their cultures were unstable, and their cultivation in the absence of carbapenems rapidly led to an overgrowth of porin-producing revertants. Analysis of the data suggests that the synergism between the lowered outer membrane permeability and the slow but significant hydrolysis of carbapenems by the overproduced enzymes can explain the resistance phenotypes quantitatively, although the possibility of alteration of the target cannot be excluded at present. With P. rettgeri mutants, there was no indication of further derepression of beta-lactamase, but the enzyme hydrolyzed imipenem much more efficiently than the E. cloacae enzyme did. In addition, the major porin was absent in one mutant strain. These results suggest that a major factor for the carbapenem resistance of these enteric bacteria is the porin deficiency, and this conclusion forms a contrast to the situation in Pseudomonas aeruginosa, in which the most prevalent class of imipenem-resistant mutants appears to lack the specific channel protein D2 yet retains the major nonspecific porin F.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1656855      PMCID: PMC284306          DOI: 10.1128/AAC.35.6.1174

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  33 in total

1.  Contribution of the cell-surface-associated enzyme in the Zimmermann-Rosselet assay of outer membrane permeability of beta-lactam antibiotics.

Authors:  W Liu; H Nikaido
Journal:  Antimicrob Agents Chemother       Date:  1991-01       Impact factor: 5.191

2.  Mutation of Salmonella paratyphi A conferring cross-resistance to several groups of antibiotics by decreased permeability and loss of invasiveness.

Authors:  L Gutmann; D Billot-Klein; R Williamson; F W Goldstein; J Mounier; J F Acar; E Collatz
Journal:  Antimicrob Agents Chemother       Date:  1988-02       Impact factor: 5.191

3.  Emergence of resistance to imipenem during therapy for Pseudomonas aeruginosa infections.

Authors:  J P Quinn; E J Dudek; C A DiVincenzo; D A Lucks; S A Lerner
Journal:  J Infect Dis       Date:  1986-08       Impact factor: 5.226

4.  Hydrolytic model for cefotaxime and ceftriaxone resistance in beta-lactamase-derepressed Enterobacter cloacae.

Authors:  D M Livermore; S J Riddle; K W Davy
Journal:  J Infect Dis       Date:  1986-03       Impact factor: 5.226

5.  Contribution of beta-lactamase hydrolysis and outer membrane permeability to ceftriaxone resistance in Enterobacter cloacae.

Authors:  B Marchou; F Bellido; R Charnas; C Lucain; J C Pechère
Journal:  Antimicrob Agents Chemother       Date:  1987-10       Impact factor: 5.191

6.  Emergence of resistance to imipenem in Pseudomonas aeruginosa.

Authors:  M J Lynch; G L Drusano; H L Mobley
Journal:  Antimicrob Agents Chemother       Date:  1987-12       Impact factor: 5.191

7.  Imipenem resistance in Pseudomonas aeruginosa resulting from diminished expression of an outer membrane protein.

Authors:  K H Büscher; W Cullmann; W Dick; W Opferkuch
Journal:  Antimicrob Agents Chemother       Date:  1987-05       Impact factor: 5.191

8.  Diffusion of beta-lactam antibiotics through the porin channels of Escherichia coli K-12.

Authors:  F Yoshimura; H Nikaido
Journal:  Antimicrob Agents Chemother       Date:  1985-01       Impact factor: 5.191

9.  Selective ceftazidime resistance in Escherichia coli: association with changes in outer membrane protein.

Authors:  J S Bakken; C C Sanders; K S Thomson
Journal:  J Infect Dis       Date:  1987-06       Impact factor: 5.226

10.  Multiply resistant mutants of Enterobacter cloacae selected by beta-lactam antibiotics.

Authors:  R L Then; P Angehrn
Journal:  Antimicrob Agents Chemother       Date:  1986-11       Impact factor: 5.191

View more
  38 in total

1.  Carbapenem resistance in Escherichia coli associated with plasmid-determined CMY-4 beta-lactamase production and loss of an outer membrane protein.

Authors:  P D Stapleton; K P Shannon; G L French
Journal:  Antimicrob Agents Chemother       Date:  1999-05       Impact factor: 5.191

2.  In vitro activities of ertapenem (MK-0826) against recent clinical bacteria collected in Europe and Australia.

Authors:  D M Livermore; M W Carter; S Bagel; B Wiedemann; F Baquero; E Loza; H P Endtz; N van Den Braak; C J Fernandes; L Fernandes; N Frimodt-Moller; L S Rasmussen; H Giamarellou; E Giamarellos-Bourboulis; V Jarlier; J Nguyen; C E Nord; M J Struelens; C Nonhoff; J Turnidge; J Bell; R Zbinden; S Pfister; L Mixson; D L Shungu
Journal:  Antimicrob Agents Chemother       Date:  2001-06       Impact factor: 5.191

3.  Interplay of impermeability and chromosomal beta-lactamase activity in imipenem-resistant Pseudomonas aeruginosa.

Authors:  D M Livermore
Journal:  Antimicrob Agents Chemother       Date:  1992-09       Impact factor: 5.191

4.  Comparative evaluation of a chromogenic agar medium, the modified Hodge test, and a battery of meropenem-inhibitor discs for detection of carbapenemase activity in Enterobacteriaceae.

Authors:  Christine Seah; Donald E Low; Samir N Patel; Roberto G Melano
Journal:  J Clin Microbiol       Date:  2011-03-23       Impact factor: 5.948

5.  Prevalence of outer membrane porin alteration in beta-lactam-antibiotic-resistant Enterobacter aerogenes.

Authors:  R N Charrel; J M Pagès; P De Micco; M Mallea
Journal:  Antimicrob Agents Chemother       Date:  1996-12       Impact factor: 5.191

6.  A rob-like gene of Enterobacter cloacae affecting porin synthesis and susceptibility to multiple antibiotics.

Authors:  E H Lee; E Collatz; I Podglajen; L Gutmann
Journal:  Antimicrob Agents Chemother       Date:  1996-09       Impact factor: 5.191

7.  Roles of beta-lactamases and porins in activities of carbapenems and cephalosporins against Klebsiella pneumoniae.

Authors:  L Martínez-Martínez; A Pascual; S Hernández-Allés; D Alvarez-Díaz; A I Suárez; J Tran; V J Benedí; G A Jacoby
Journal:  Antimicrob Agents Chemother       Date:  1999-07       Impact factor: 5.191

8.  Identification of a novel multidrug efflux pump of Mycobacterium tuberculosis.

Authors:  Olga Danilchanka; Claudia Mailaender; Michael Niederweis
Journal:  Antimicrob Agents Chemother       Date:  2008-05-05       Impact factor: 5.191

9.  Cloning and sequence analysis of the gene for a carbapenem-hydrolyzing class A beta-lactamase, Sme-1, from Serratia marcescens S6.

Authors:  T Naas; L Vandel; W Sougakoff; D M Livermore; P Nordmann
Journal:  Antimicrob Agents Chemother       Date:  1994-06       Impact factor: 5.191

10.  Imipenem resistance in Enterobacter.

Authors:  K S Thomson; C C Sanders; H Chmel
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1993-08       Impact factor: 3.267

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.